FDA Approved: IRBESARTAN — Supplemental Application (Chartwell RX, LLC)

View source ↗

Summary

The FDA approved a supplemental application for IRBESARTAN filed by Chartwell RX, LLC under the ANDA umbrella, indicating an approved change related to the prod…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Irbesartan (irbesartan)

Snippet

SUPPL AP for IRBESARTAN (IRBESARTAN)